サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1676255

幹細胞バンキングの世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）

Global Stem Cell Banking Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 169 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
幹細胞バンキングの世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 169 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の幹細胞バンキングの市場規模は、2024年の106億4,000万米ドルから2033年までには228億1,000万米ドルに成長すると予測され、2026年から2033年の予測期間中に8.84％の堅調な年間平均成長率（CAGR）を示します。

幹細胞バンキング市場は、幹細胞の治療可能性に対する意識の高まりと再生医療への需要の高まりによって、大きく成長する見込みです。がん、神経疾患、心血管疾患など、様々な疾患の治療における幹細胞の能力が研究によって明らかにされつつある中、信頼性の高い幹細胞保管ソリューションのニーズが急増しています。幹細胞バンクは、幹細胞の収集、加工、保存のための安全な環境を提供し、将来の治療応用のための生存性を確保します。凍結保存技術やバイオバンキング技術の革新により、幹細胞保存の効率性と安全性が向上し、医療提供者と患者の双方にとって魅力的なサービスとなっています。

さらに、個別化医療への関心の高まりが幹細胞バンキング市場に影響を与えています。医療提供者が患者一人ひとりのニーズに合わせた治療を行うことの重要性を認識するようになるにつれ、患者自身の幹細胞を将来の使用のために保存する自己幹細胞バンクの需要が高まっています。この動向は、患者自身の細胞を使用することで、拒絶反応のリスクを軽減し、治療成績を向上させることができる再生治療において特に関連性が高いです。さらに、提供された幹細胞を保管する公的な幹細胞バンクの台頭は、市場を拡大し、研究や臨床応用における幹細胞の利用を促進しています。

さらに、幹細胞治療分野における研究開発への注目の高まりが、幹細胞バンキング市場のイノベーションを促進しています。学術機関、研究機関、バイオ製薬企業による共同研究が幹細胞技術の進歩を促し、新たな採取・保存方法が市場の進化するニーズに応えることを確実にしています。幹細胞バンキングの利点に対する消費者の認識が高まっていることも、市場の成長に寄与しています。

当レポートは、様々な産業や市場に関する包括的かつ実用的な洞察をお客様に提供できるよう、綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます：

市場概要：定義、分類、業界の現状など、市場に関する詳細なイントロダクション。

市場力学：市場成長に影響を与える主な促進要因・抑制要因・機会・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳します。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場プレイヤーの包括的評価をします。主要企業が採用する競合力学と主要戦略に関する考察を提供します。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測します。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域ごとの市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネスチャンスを理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象分野を特定します。将来の市場開拓と成長見通しに関する洞察を提供します。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 幹細胞バンキング産業分析

  • イントロダクション-市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル開発動向

第5章 幹細胞バンキングの世界市場分析：ソース別

  • 概要：ソース別
  • 過去と予測データ分析：ソース別
  • 胎盤幹細胞（PSCS）
  • 脂肪組織由来幹細胞（ADSCS）
  • 骨髄由来幹細胞（BMSCS）
  • ヒト胚由来幹細胞（HESCS）
  • 歯髄由来幹細胞（DPSCS）
  • その他

第6章 幹細胞バンキングの世界市場分析：サービスタイプ別

  • 概要：サービスタイプ別
  • 過去と予測データ分析：サービスタイプ別
  • サンプルの保存と保管
  • サンプル分析
  • サンプル処理
  • 検体の収集と輸送

第7章 幹細胞バンキングの世界市場分析：用途別

  • 概要：用途別
  • 過去と予測データ分析：用途別
  • パーソナライズドバンキング用途
  • 調査用途
  • 臨床用途

第8章 幹細胞バンキングの世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋の売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋
  • ラテンアメリカの売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカの売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第9章 幹細胞バンク企業の競合情勢

  • 幹細胞バンキング市場競合
  • パートナーシップ/提携/合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Cord Blood Registry（CBR）Systems
  • Cordlife Group Limited
  • Cryo-Cell International
  • ViaCord
  • Cryo-Save AG
  • LifeCell International
  • StemCyte
  • Global Cord Blood Corporation
  • Smart Cells International
  • Vita34 AG
  • CryoHoldco
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Source (USD MN)
  • Placental Stem Cells (PSCS) Market Sales By Geography (USD MN)
  • Adipose Tissue-Derived Stem Cells (ADSCS) Market Sales By Geography (USD MN)
  • Bone Marrow-Derived Stem Cells (BMSCS) Market Sales By Geography (USD MN)
  • Human Embryo-Derived Stem Cells (HESCS) Market Sales By Geography (USD MN)
  • Dental Pulp-Derived Stem Cells (DPSCS) Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Service Type (USD MN)
  • Sample Preservation and Storage Market Sales By Geography (USD MN)
  • Sample Analysis Market Sales By Geography (USD MN)
  • Sample Processing Market Sales By Geography (USD MN)
  • Sample Collection and Transportation Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Personalized Banking Applications Market Sales By Geography (USD MN)
  • Research Applications Market Sales By Geography (USD MN)
  • Clinical Application Market Sales By Geography (USD MN)
  • Global Stem Cell Banking Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Stem Cell Banking Report
  • Market Research Process
  • Market Research Methodology
  • Global Stem Cell Banking Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Source
  • Market Attractiveness Analysis By Service Type
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Source (USD MN)
  • Placental Stem Cells (PSCS) Market Sales By Geography (USD MN)
  • Adipose Tissue-Derived Stem Cells (ADSCS) Market Sales By Geography (USD MN)
  • Bone Marrow-Derived Stem Cells (BMSCS) Market Sales By Geography (USD MN)
  • Human Embryo-Derived Stem Cells (HESCS) Market Sales By Geography (USD MN)
  • Dental Pulp-Derived Stem Cells (DPSCS) Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Service Type (USD MN)
  • Sample Preservation and Storage Market Sales By Geography (USD MN)
  • Sample Analysis Market Sales By Geography (USD MN)
  • Sample Processing Market Sales By Geography (USD MN)
  • Sample Collection and Transportation Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Personalized Banking Applications Market Sales By Geography (USD MN)
  • Research Applications Market Sales By Geography (USD MN)
  • Clinical Application Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次
Product Code: VMR11211839

Global Stem Cell Banking Market size is anticipated to grow from USD 10.64 Billion in 2024 to USD 22.81 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 8.84% during the forecast period of 2026 to 2033.

The stem cell banking market is poised for significant growth, driven by the increasing awareness of the therapeutic potential of stem cells and the rising demand for regenerative medicine. As research continues to unveil the capabilities of stem cells in treating various diseases, including cancer, neurological disorders, and cardiovascular diseases, the need for reliable stem cell storage solutions is surging. Stem cell banks provide a secure environment for the collection, processing, and storage of stem cells, ensuring their viability for future therapeutic applications. Innovations in cryopreservation techniques and biobanking technologies are enhancing the efficiency and safety of stem cell storage, making these services more appealing to both healthcare providers and patients.

Moreover, the growing emphasis on personalized medicine is influencing the stem cell banking market. As healthcare providers increasingly recognize the importance of tailoring treatments to individual patient needs, the demand for autologous stem cell banking-where patients store their own stem cells for future use-is rising. This trend is particularly relevant in the context of regenerative therapies, where the use of a patient's own cells can reduce the risk of rejection and improve treatment outcomes. Additionally, the rise of public stem cell banks, which offer accessible storage options for donated stem cells, is expanding the market and promoting the use of stem cells in research and clinical applications.

Furthermore, the increasing focus on research and development in the field of stem cell therapy is fostering innovation in the stem cell banking market. Collaborations between academic institutions, research organizations, and biopharmaceutical companies are driving advancements in stem cell technologies, ensuring that new methods for collection and storage meet the evolving needs of the market. The growing awareness of the benefits of stem cell banking among consumers is also contributing to market growth, as more individuals seek to secure their health and wellness through stem cell preservation.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Source

  • Placental Stem Cells (PSCS)
  • Adipose Tissue-Derived Stem Cells (ADSCS)
  • Bone Marrow-Derived Stem Cells (BMSCS)
  • Human Embryo-Derived Stem Cells (HESCS)
  • Dental Pulp-Derived Stem Cells (DPSCS)
  • Others

By Service Type

  • Sample Preservation and Storage
  • Sample Analysis
  • Sample Processing
  • Sample Collection and Transportation

By Application

  • Personalized Banking Applications
  • Research Applications
  • Clinical Application
  • COMPANIES PROFILED
  • Cord Blood Registry (CBR) Systems
  • Cordlife Group Limited
  • Cryo-Cell International
  • ViaCord
  • Cryo-Save AG
  • LifeCell International
  • StemCyte
  • Global Cord Blood Corporation
  • Smart Cells International
  • Vita34 AG
  • CryoHoldco
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. STEM CELL BANKING INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Source
    • 3.7.2 Market Attractiveness Analysis By Service Type
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL STEM CELL BANKING MARKET ANALYSIS BY SOURCE

  • 5.1. Overview By Source
  • 5.2. Historical and Forecast Data Analysis By Source
  • 5.3. Placental Stem Cells (PSCS) Historic and Forecast Sales By Regions
  • 5.4. Adipose Tissue-Derived Stem Cells (ADSCS) Historic and Forecast Sales By Regions
  • 5.5. Bone Marrow-Derived Stem Cells (BMSCS) Historic and Forecast Sales By Regions
  • 5.6. Human Embryo-Derived Stem Cells (HESCS) Historic and Forecast Sales By Regions
  • 5.7. Dental Pulp-Derived Stem Cells (DPSCS) Historic and Forecast Sales By Regions
  • 5.8. Others Historic and Forecast Sales By Regions

6. GLOBAL STEM CELL BANKING MARKET ANALYSIS BY SERVICE TYPE

  • 6.1. Overview By Service Type
  • 6.2. Historical and Forecast Data Analysis By Service Type
  • 6.3. Sample Preservation and Storage Historic and Forecast Sales By Regions
  • 6.4. Sample Analysis Historic and Forecast Sales By Regions
  • 6.5. Sample Processing Historic and Forecast Sales By Regions
  • 6.6. Sample Collection and Transportation Historic and Forecast Sales By Regions

7. GLOBAL STEM CELL BANKING MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. Personalized Banking Applications Historic and Forecast Sales By Regions
  • 7.4. Research Applications Historic and Forecast Sales By Regions
  • 7.5. Clinical Application Historic and Forecast Sales By Regions

8. GLOBAL STEM CELL BANKING MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE STEM CELL BANKING COMPANIES

  • 9.1. Stem Cell Banking Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF STEM CELL BANKING INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Cord Blood Registry (CBR) Systems
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Cordlife Group Limited
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Cryo-Cell International
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. ViaCord
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Cryo-Save AG
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. LifeCell International
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. StemCyte
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Global Cord Blood Corporation
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Smart Cells International
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Vita34 AG
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. CryoHoldco
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies